[Federal Register Volume 66, Number 130 (Friday, July 6, 2001)]
[Notices]
[Pages 35646-35650]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-16988]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA 225-00-4001]


Memorandum of Understanding Between the Maryland Department of 
Health and Mental Hygiene and the Food and Drug Administration

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between the Maryland Department of 
Health and Mental Hygiene and the Food and Drug Administration. The 
purpose is to set forth conditions for the utilization of Maryland 
Medicaid data for the study entitled ``Compliance with Liver Testing 
Labeling Guidelines by Health Care Providers.''

DATES: The agreement became effective December 12, 2000.

FOR FURTHER INFORMATION CONTACT: Katrina S. Garry, Center for Drug 
Evaluation and Research (HFD-400), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-3192.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: June 29, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.

BILLING CODE 4160-01-C

[[Page 35647]]

[GRAPHIC] [TIFF OMITTED] TN06JY01.018


[[Page 35648]]


[GRAPHIC] [TIFF OMITTED] TN06JY01.019


[[Page 35649]]


[GRAPHIC] [TIFF OMITTED] TN06JY01.020


[[Page 35650]]


[GRAPHIC] [TIFF OMITTED] TN06JY01.021


[FR Doc. 01-16988 Filed 7-5-01; 8:45 am]
BILLING CODE 4160-01-C